Bicyclol
- Generic Name
- Bicyclol
- Drug Type
- Small Molecule
- Chemical Formula
- C19H18O9
- CAS Number
- 118159-48-1
- Unique Ingredient Identifier
- 9734122TH2
- Background
Bicyclol is under investigation in clinical trial NCT02944552 (The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILI).
- Indication
用于治疗慢性肝炎所致的氨基转移酶升高。
Bicyclol in the Treatment of Antineoplastic Drug-induced Liver Injury.
Not Applicable
Recruiting
- Conditions
- Drug-Induced Acute Liver Injury
- Interventions
- First Posted Date
- 2023-02-03
- Last Posted Date
- 2023-02-03
- Target Recruit Count
- 5405
- Registration Number
- NCT05711459
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China
The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILI
Phase 2
Completed
- Conditions
- Drug-Induced Acute Liver Injury
- Interventions
- First Posted Date
- 2016-10-26
- Last Posted Date
- 2020-04-28
- Lead Sponsor
- Drug Induced Liver Disease Study Group
- Target Recruit Count
- 244
- Registration Number
- NCT02944552
- Locations
- 🇨🇳
Beijing Chest Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Beijing Ditan Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Henan Provincial People's Hospital, Zhengzhou, Henan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath